ACP

Acuta Capital Partners Portfolio holdings

AUM $71.6M
1-Year Return 169.78%
This Quarter Return
-1.02%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$238M
AUM Growth
-$43.1M
Cap. Flow
-$23.3M
Cap. Flow %
-9.8%
Top 10 Hldgs %
62.29%
Holding
58
New
11
Increased
7
Reduced
11
Closed
21

Top Buys

1
APLS icon
Apellis Pharmaceuticals
APLS
$21.7M
2
RLMD icon
Relmada Therapeutics
RLMD
$9.1M
3
PYXS icon
Pyxis Oncology
PYXS
$7.44M
4
MRUS icon
Merus
MRUS
$3.61M
5
VRDN icon
Viridian Therapeutics
VRDN
$3.6M

Top Sells

1
BLU
BELLUS Health Inc.
BLU
$11.9M
2
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$11.1M
3
CLSD icon
Clearside Biomedical
CLSD
$7.9M
4
XENE icon
Xenon Pharmaceuticals
XENE
$6.01M
5
RNAC icon
Cartesian Therapeutics
RNAC
$4.26M

Sector Composition

1 Healthcare 92.25%
2 Financials 5.78%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
EYPT icon
26
EyePoint Pharmaceuticals
EYPT
$966M
$2.98M 1.25%
243,072
-126,791
-34% -$1.55M
MRTX
27
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$2.93M 1.23%
+20,000
New +$2.93M
ALDX icon
28
Aldeyra Therapeutics
ALDX
$334M
$2M 0.84%
+500,000
New +$2M
SRRA
29
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$1.49M 0.63%
+68,500
New +$1.49M
ACRS icon
30
Aclaris Therapeutics
ACRS
$227M
$1.43M 0.6%
98,000
-42,839
-30% -$623K
GOSS icon
31
Gossamer Bio
GOSS
$668M
$1.36M 0.57%
119,843
-95,157
-44% -$1.08M
MTEM
32
DELISTED
Molecular Templates, Inc.
MTEM
$1.26M 0.53%
+21,500
New +$1.26M
GRTX
33
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$1.21M 0.51%
+262,500
New +$1.21M
JNCE
34
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$1.07M 0.45%
+127,500
New +$1.07M
NUVB icon
35
Nuvation Bio
NUVB
$1.33B
$172K 0.07%
+90,832
New +$172K
ALLK
36
DELISTED
Allakos
ALLK
– –
-17,500
Closed -$1.85M
ALT icon
37
Altimmune
ALT
$334M
– –
-150,000
Closed -$1.7M
AVDL
38
Avadel Pharmaceuticals
AVDL
$1.53B
– –
0
– –
BCYC
39
Bicycle Therapeutics
BCYC
$496M
– –
-38,184
Closed -$1.59M
CABA icon
40
Cabaletta Bio
CABA
$155M
– –
-302,926
Closed -$3.68M
CCCC icon
41
C4 Therapeutics
CCCC
$194M
– –
-21,000
Closed -$938K
CLSD icon
42
Clearside Biomedical
CLSD
$27.2M
– –
-1,316,268
Closed -$7.9M
ELAN icon
43
Elanco Animal Health
ELAN
$9.16B
– –
-29,000
Closed -$925K
GYRE icon
44
Gyre Therapeutics
GYRE
$698M
– –
-48,667
Closed -$1.5M
KRYS icon
45
Krystal Biotech
KRYS
$4.35B
– –
-72,551
Closed -$3.79M
NUVB.WS icon
46
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$64.6M
– –
-90,832
Closed -$242K
NVAX icon
47
Novavax
NVAX
$1.28B
– –
-2,315
Closed -$480K
OLMA icon
48
Olema Pharmaceuticals
OLMA
$570M
– –
-150,500
Closed -$4.15M
RNA icon
49
Avidity Biosciences
RNA
$6.48B
– –
-60,000
Closed -$1.48M
RNAC icon
50
Cartesian Therapeutics
RNAC
$277M
– –
-34,156
Closed -$4.26M
1
2
3